Randomized, double blind, placebo controlled clinical study to assess efficacy and safety of NRL/MW/201901 in subjects suffering from erectile dysfunction

Omkar Kulkarni (1) , Anuj Agarwal (2) , Priya Khare (3) , Gayatri Ganu (4)
(1) R and D Healthcare, Netsurf Research Labs Pvt. Ltd, Baner Pune, Maharashtra, India, India ,
(2) R and D Healthcare, Netsurf Research Labs Pvt. Ltd, Baner Pune, Maharashtra, India, India ,
(3) R and D Healthcare, Netsurf Research Labs Pvt. Ltd, Baner Pune, Maharashtra, India, India ,
(4) Clinical Research, Mprex Healthcare, 414, Nisarg Plaza, Bhumkar Nagar, Wakad, Pune – 411057, Maharashtra, India, India

Abstract

Sex is an integral part of a well-being. Sexual satisfaction is the most important component of the quality of life. In management of ED overall sexual potential and quality of life needs to be taken care of as a holistic approach to management. The aim of the study was to clinically validate effect of NRL/MW/201901 a polyhedral Nutraceutical product in ED. The clinical efficacy of NRL/MW/201901 in patients suffering from erectile dysfunction was evaluated by assessing Quality of Erection Questionnaire and sexual encounter profile with Intra-vaginal ejaculation latency time, serum testosterone and anthropometric analysis etc. NRL/MW/201901 was effective in increasing erection function, orgasmic function, intercourse satisfaction, overall satisfaction and sexual desire. There is marked increase in number of sexual encounters in NRL/MW/201901 treated group. Serum levels of testosterone were increased after treatment of NRL/MW/201901 than in placebo group. It was evident from the anthropometric analysis of the subjects that there was significant increase in resting metabolism and % skeletal muscle content in NRL/MW/201901 treated group. There were no evident adverse events related to drug. Thus it could be concluded that NRL/MW/201901 is safe and effective in the treatment of mild to moderate erectile dysfunction.

Full text article

Generated from XML file

Authors

Omkar Kulkarni
omkar.kulkarni@nrl.net.in (Primary Contact)
Anuj Agarwal
Priya Khare
Gayatri Ganu
Omkar Kulkarni, Anuj Agarwal, Priya Khare, & Gayatri Ganu. (2020). Randomized, double blind, placebo controlled clinical study to assess efficacy and safety of NRL/MW/201901 in subjects suffering from erectile dysfunction. International Journal of Research in Pharmaceutical Sciences, 11(3), 2790–2801. Retrieved from https://ijrps.com/home/article/view/461

Article Details

Most read articles by the same author(s)

No Related Submission Found